ERBB2 and breast carcinoma: (11), with subsequent studies demonstrating its impact on survival rates and prognosis for specific solid tumors such as HER2-positive breast cancer in elderly females (17), sinonasal squamous cell carcinoma (18), gastric cancer (19), renal cell carcinoma (20)and surgically treated PC (21).